Dergiler / Turkish Journal of Hematology / 2014 / Cilt: 31 - Sayı: 2

The Role of Radiotherapy Among the Therapeutic Options for Castleman's Disease

Sayfa
99–100
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

KARACA, F. (2014). The Role of Radiotherapy Among the Therapeutic Options for Castleman's Disease. Turkish Journal of Hematology, Cilt: 31 - Sayı: 2, 99–100. https://ajindex.com/articles/412827

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 1988;5:346-364
  2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670- 683
  3. Herrada J, Cabanillas F, Rice L, Maning J, Puph W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998;128:657-662
  4. Weysenburger DD, Nathwany BN, Wynberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 1985;16:162-172
  5. Chan JKL, Tsang WYW. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease. Am J Surg Pathol 1994;18:517-525
  6. Gerald W, Kostianovsky M, Rosai J. Development of vascular neoplasia in Castleman's disease. Report of seven cases. Am J Surg Pathol 1990;14:603-614
  7. Dickson D, Ben-Ezra JM, Reed J, Flax H, Janis R. Multicentric giant lymph node hyperplasia, Kaposi's sarcoma, and lymphoma. Arch Pathol Lab Med 1985;109:1013-1018
  8. Hsu SM, Waldron JA, Xie SS, Barlogie B. Expression of interleukin-6 in Castleman's disease. Hum Pathol 1993;24:833-839
  9. Herbelin C, Roux-Lombard P, Herbelin A, Peuchmaur M, De Groote D, Griscelli C, Dayer JM, Prieur AM. Inflammation: "a natural experiment" for the systemic pathogenicity of cytokines. Eur Cytokine Netw 1998;9:57-60
  10. Ozkan H, Tolunay S, Gozu O, Ozer ZG. Giant lymphoid hamartoma of mediastinum (Castleman's disease). Thorac Cardiovasc Surg 1990;38:321-323
  11. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001;92:670- 676
  12. Li YM, Liu PH, Zhang YH, Xia HS, Li LL, Qu YM, Wu Y, Han SY, Liao GQ, Pu YD. Radiotherapy of unicentric mediastinal Castleman's disease. Chin J Cancer 2011;30:351-356
  13. Noh OK, Lee SW, Lee JW, Kim SY, Kim CS, Choi EK, Kim JH, Ahn SD. Cases report of unicentric Castleman's disease: revisit of radiotherapy role. Radiat Oncol J 2013;31:48-54
  14. Matthiesen C, Ramgopol R, Seavey J, Ahmad S, Herman T. Intensity modulated radiationtherapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature. Radiol Oncol 2012;46:265-270.